Compare Rubicon Organics, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 35 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.18
-36.55%
0.79
Revenue and Profits:
Net Sales:
16 Million
(Quarterly Results - Dec 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.91%
0%
15.91%
6 Months
3.03%
0%
3.03%
1 Year
6.25%
0%
6.25%
2 Years
50.0%
0%
50.0%
3 Years
-7.27%
0%
-7.27%
4 Years
-40.0%
0%
-40.0%
5 Years
-83.22%
0%
-83.22%
Rubicon Organics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
65.47%
EBIT Growth (5y)
4.41%
EBIT to Interest (avg)
-14.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.98
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.26%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.74
EV to EBIT
-2.69
EV to EBITDA
-3.53
EV to Capital Employed
0.76
EV to Sales
0.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.08%
ROE (Latest)
-32.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (2.26%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
16.50
15.60
5.77%
Operating Profit (PBDIT) excl Other Income
-4.60
-2.20
-109.09%
Interest
0.20
0.20
Exceptional Items
3.60
6.00
-40.00%
Consolidate Net Profit
-2.20
2.80
-178.57%
Operating Profit Margin (Excl OI)
-340.50%
-188.80%
-15.17%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 5.77% vs 4.00% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -178.57% vs 250.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
59.50
48.70
22.18%
Operating Profit (PBDIT) excl Other Income
-12.00
-11.00
-9.09%
Interest
0.70
1.10
-36.36%
Exceptional Items
17.20
13.60
26.47%
Consolidate Net Profit
1.10
-2.60
142.31%
Operating Profit Margin (Excl OI)
-257.90%
-293.50%
3.56%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 22.18% vs 21.45% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 142.31% vs -44.44% in Dec 2024
About Rubicon Organics, Inc. 
Rubicon Organics, Inc.
Pharmaceuticals & Biotechnology
Rubicon Organics Inc is a Canada-based company engaged in cannabis business sector. The Company is a organic cannabis company with operations in Canada, California and Washington. The Company, through its subsidiary Vintages Organic Cannabis Company Inc, is a late-stage applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Company Coordinates 
Company Details
505 - 744 West Hastings Street , VANCOUVER BC : V6C 1A5
Registrar Details






